A request for “Flavocare 200” is incomplete until you confirm the active ingredient, dosage form and approved directions printed on the pack. By the end, you will know how to check whether the product contains flavoxate hydrochloride 200 mg, how to handle its use safely, and what batch and supplier documents to request before placing an order.
Key takeaways
- Confirm the active ingredient, strength, dosage form and release type on the pack.
- Follow verified flavoxate directions from a qualified healthcare professional.
- Reject packs with broken seals, missing batch numbers or unclear expiry dates.
- Ask a Zirakpur supplier for licence details and traceable invoices.
Confirm What “Flavocare 200” Actually Contains
The number “200” and the brand name do not identify the active ingredient, dosage form or release type. Before deciding how to use or order it, verify the flavocare 200 medicine details on the actual strip or carton.
- Active ingredient and strength
- Tablet, capsule or other dosage-form description
- Manufacturer and marketer
- Batch number
- Manufacturing licence details
- Manufacturing date and expiry date
2. If the pack states flavoxate hydrochloride 200 mg, it identifies a urinary-tract antispasmodic. It provides symptomatic relief from urgency, frequency, dysuria, nocturia and bladder discomfort associated with cystitis, prostatitis, urethritis and urethrocystitis. It relaxes bladder-muscle spasm; it does not treat a bacterial infection or remove the underlying cause.
3. Do not assume that “200” means immediate-release. It does not establish immediate-release or modified-release formulation, and it does not prove whether the product is a tablet or capsule. Compare the pack with the quotation before accepting an order.
4. Obtain the approved package insert or dispensing label before applying any dosage instruction. The commonly documented adult schedule for standard immediate-release flavoxate tablets cannot automatically be used for a product labelled “200.” Use the confirmed formulation and the prescriber’s directions, not the brand number alone.
Follow the Confirmed Flavoxate Directions, Not the Brand Number
Documented adult dosing for standard immediate-release flavoxate tablets is commonly 100–200 mg three or four times daily, followed by a reduction after symptoms improve. Do not apply that schedule automatically to a product labelled “200”: how to use flavocare 200 depends on the confirmed formulation, the prescriber’s directions and the approved local product information.
For flavocare 200 usage, follow these instructions:
- Take it by mouth at regularly spaced times with water.
- Follow the supplied label for whether to take it with food.
- Do not crush, split or alter the tablet if the label gives special release instructions.
- Take a missed dose when you remember unless the next dose is near; skip it instead of doubling.
- Do not stop solely because symptoms improve. Confirm the treatment plan first, because relief from bladder spasm does not remove the underlying cause.
The pack’s dispensing directions override a generic internet dosage statement, especially for a 200-mg presentation whose release type is not confirmed. If urgency, frequency or discomfort returns, arrange clinical assessment instead of repeatedly extending self-treatment. Fever, flank pain, blood in the urine or difficulty passing urine needs prompt medical review.
Check Contraindications, Side Effects and Urgent Symptoms
Before supply or use, confirm the Flavocare 200 medicine details and screen the patient. Flavoxate can cause dry mouth, nausea, vomiting, stomach upset, blurred vision, headache, dizziness, drowsiness or weakness. Avoid driving and machinery until the patient knows its effects; stop immediately if marked drowsiness or blurred vision develops, then seek professional advice.
Obtain pharmacist or prescriber review before supply when the patient has:
- Glaucoma risk, urinary retention, lower-urinary-tract obstruction, or suspected difficulty emptying the bladder
- Obstructive gastrointestinal disease, paralytic ileus, gastrointestinal bleeding, achalasia or significant gastrointestinal motility problems
- Pregnancy or breastfeeding
- A child who may need paediatric treatment
- Current medicines with anticholinergic effects
When the full composition is not confirmed, also ask about medicines or supplements that affect alertness, blood pressure or bleeding. Do not assume a urinary medicine is free from sedation or interaction risk.
| Finding | What to do | Why it matters |
|---|---|---|
| Fever or flank pain | Arrange clinical assessment | Infection or upper-tract disease needs investigation |
| Haematuria | Arrange clinical assessment | Blood in urine needs a cause identified |
| Inability to urinate | Treat as urgent and seek medical care | Flavoxate is unsuitable when retention is possible |
| Suspected obstruction | Do not repeat symptomatic treatment | Obstruction requires examination and treatment |
| Recurrent symptoms | Reassess rather than extending use | Flavoxate relieves bladder spasm but does not remove the underlying cause |
Inspect the Pack, Batch and Storage Conditions
At delivery, inspect every batch before it enters stock. Compare the quotation with the carton and strip for active ingredient, strength, dosage form, directions, manufacturer, batch number, manufacturing date and expiry date. Record the Flavocare 200 medicine details against the invoice.
| Check | Accept | Quarantine or reject |
|---|---|---|
| Composition and directions | Active ingredient, strength, dosage form and directions match the quotation | Any mismatch, including an unapproved flavoxate strength or presentation |
| Dates and coding | Manufacturing date, expiry date and batch number are printed and readable | Missing, altered or unreadable batch or expiry details |
| Packaging | Outer carton is sealed; inner strip is intact and matches the carton | Damaged strip, broken seal, moisture, discolouration or altered tablets |
| Traceability | Invoice identifies the seller, product and batch | No invoice or insufficient batch traceability |
| Storage | Pack remains dry and follows its printed storage statement | Evidence of excessive heat or unsuitable storage |
Retain the invoice with the receiving record. Ask for a certificate of analysis or other quality documentation when your quality system requires it, and obtain the seller’s applicable drug licence details.
Flavoxate tablets are normally stored at controlled room temperature, in a dry place and in the original container. They do not normally require cold-chain handling, but the storage statement printed on the supplied pack governs transport and warehouse conditions.
Do not release questionable stock because its unit price is lower. Missing traceability cannot be repaired by a discount.
Use a Zirakpur Supplier Check Before You Place the Order
A Flavocare 200 supplier in Zirakpur should provide a current product-pack image or approved insert before giving you a quotation. The brand name and “200” are not enough: verify the active ingredient, strength, tablet or capsule form, directions and release type.
Ask the supplier to confirm in writing that the supplied batch will match the quoted:
- Composition and strength
- Dosage form and approved directions
- Manufacturer or marketer details
- Batch number, manufacturing date and expiry date
- Storage statement and transport conditions
Require written approval before accepting a different flavoxate strength, tablet presentation or release type. Do not treat a lower price as permission to substitute.
| Supplier response | What it proves | Your decision |
|---|---|---|
| Complete pack and insert, licence details, batch records and invoice trail | The medicine and source are identifiable | Proceed to quality review |
| Different strength or presentation offered after quotation | The proposed stock does not match the agreed product | Accept only after written approval |
| Price offered without clear batch, licence or quality documents | Cost is documented better than the medicine | Do not commit |
Check the seller’s applicable drug licence details, invoice traceability, packaging condition and certificate of analysis or other quality documents required by your quality system. Confirm that the seller will keep the pack’s stated dry, controlled-room-temperature conditions from dispatch to delivery.
Macro Labs Pvt Ltd can be compared with other regional sources for a PCD or distribution order only after these product and batch questions receive clear answers. The practical choice is traceable, correctly identified stock—not the cheapest quotation.
Related product
 | Flavocare-200 by Macro Labs Pvt. Ltd. is a powerful flavonoid-based formulation designed to strengthen blood vessels and support vascular health. View product → |
Frequently asked questions
What should you confirm before using Flavocare 200?
Read the actual strip or carton and confirm the active ingredient, strength, dosage form and release type. Do not rely on the brand name or the number 200 alone.
Should you follow directions based only on the number 200?
No. Confirm the medicine composition and formulation first, then follow the directions provided by a qualified healthcare professional or the verified product information.
Which warning signs require urgent medical attention?
Seek urgent medical help for severe allergic symptoms, trouble breathing, facial or throat swelling, fainting or other serious symptoms after taking the medicine.
What should you inspect before ordering from a Zirakpur supplier?
Check the seal, batch number, manufacturing and expiry dates, storage condition, invoice and supplier licence details. Do not accept a pack with missing or altered information.
Keywords
